Yu Xiang

5.1k total citations
75 papers, 2.9k citations indexed

About

Yu Xiang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Yu Xiang has authored 75 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 15 papers in Cancer Research and 13 papers in Immunology. Recurrent topics in Yu Xiang's work include Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (11 papers) and Hepatitis C virus research (6 papers). Yu Xiang is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (11 papers) and Hepatitis C virus research (6 papers). Yu Xiang collaborates with scholars based in China, United States and Canada. Yu Xiang's co-authors include Leng Han, Lixia Diao, Youqiong Ye, Chunjie Liu, An‐Yuan Guo, Chunru Lin, Zhao Zhang, Jing Gong, Jin Zhong and Siyu Xia and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Yu Xiang

71 papers receiving 2.9k citations

Peers

Yu Xiang
Comparison fields: 5 of 148
  • Molecular Biology 2.0k
  • Cancer Research 1.1k
  • Immunology 419
  • Oncology 263
  • Epidemiology 176
Replace Wen Pan with:
Wen Pan China
Dongmei Lai China
Yunlong Yang China
Liang Liang China
Zongyou Chen China
Jianhua Zhu China
Patricia A. Kruk United States
Helen He Zhu China
Wen Pan China View profile →
Citations per field, relative to Yu Xiang
Yu Xiang · 1×
Citations per year, relative to Yu Xiang
Yu Xiang · 1×

Countries citing papers authored by Yu Xiang

Since Specialization
Citations

This map shows the geographic impact of Yu Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Xiang more than expected).

Fields of papers citing papers by Yu Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Xiang. The network helps show where Yu Xiang may publish in the future.

Co-authorship network of co-authors of Yu Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Xiang. A scholar is included among the top collaborators of Yu Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Xiang. Yu Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 3
4 1
5 6
6 2
7 2
8 25
9 22
10 0
11 2
12 23
13 134
14 25
15 197
16 12
17 101
18 19
19 46
20
Construction of recombined plasmid carrying Cry1Ac gene and expression of insecticidal activities in Bacillus subtilis
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026